Avion Wealth’s Achieve Life Sciences ACHV Stock Holding History

Avion Wealth’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3K	Hold	500	–	–	﹤0.01%	900
2026 Q1	$1K	Buy	+500	New	+$2.22K	﹤0.01%	952

Other funds holding ACHV

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Avion Wealth's ACHV Position: Q2 2026 in Review

Avion Wealth held its Achieve Life Sciences (ACHV) position steady in Q2 2026 at 500 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #900.

Avion Wealth first reported a position in ACHV in Q1 2026 and has held it in 2 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

Avion Wealth held 500 shares of Achieve Life Sciences worth $3K as of Q2 2026.
Avion Wealth left its Achieve Life Sciences share count unchanged in Q2 2026.
Achieve Life Sciences made up ﹤0.01% of Avion Wealth's portfolio in Q2 2026, its #900 holding.
Avion Wealth first reported a position in Achieve Life Sciences in Q1 2026 and has held it in 2 quarters since.
111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.